Everolimus Post Pazopanib Treatment in Metastatic or Advanced Renal Cell Carcinoma
Clinical trial NCT01545817 · TERMINATED
Trial details
- NCT number
- NCT01545817
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-19
- Primary completion
- 2016-11-18
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.